8 December 2022
Biotech company Alvotech has now moved its shares listed under the ticker symbol “ALVO” from First North Iceland to the Main Market on Nasdaq Iceland.
Since June 2022, shares in Alvotech have been dual-listed on the First North market in Iceland and the Nasdaq Stock Market in the US. The move entails that the company’s share listing has been transferred from First North to the Main Market of Nasdaq Iceland. Alvotech’s shares are now dual-listed on the Nasdaq Iceland Main Market and the Nasdaq US Stock Exchange.
Landsbankinn Corporate Finance managed the process of moving the listing to the Nasdaq Main Market in Iceland.
Our congratulations to the shareholders and employees of Alvotech!
You may also be interested in
14 Oct. 2026
Landsbankinn wishes to draw customers’ attention to an investigation by the Reykjavík Metropolitan Police, which revealed that over 300 young people have used an iPhone VPN profile called “Island Surge VPN”.
2 Oct. 2026
Styrkás hf. has signed an agreement to acquire all shares in Malbikstöðin ehf. and the company’s sites at Esjumelar. Landsbankinn Corporate Finance acted as advisor to Styrkás in the transaction.
29 Sept. 2026
Each year we award community grants from Landsbankinn’s Community Fund in the total amount of ISK 20 million.
10 Sept. 2026
University students Salvador Di Marzio Láruson and Oliwia Slodowska are the recipients of grants from Landsbankinn’s Hvatasjóður fund for undergraduate studies at Reykjavík University (RU) 2027-2028.